ID

17310

Beschreibung

Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00619697

Link

https://clinicaltrials.gov/show/NCT00619697

Stichworte

  1. 06.09.16 06.09.16 -
Hochgeladen am

6. September 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT00619697

Eligibility Diabetes NCT00619697

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00619697
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes for at least 6 months
Beschreibung

Non-Insulin-Dependent Diabetes Mellitus disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
insulin naive. short term insulin treatment (7 days or less within the last 6 months) is allowed
Beschreibung

Insulin Therapy naive | Insulin, Short-Acting

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
UMLS CUI [2]
C0356365
previous treatment with oral antidiabetic drugs for at least 4 months
Beschreibung

Oral hypoglycemic

Datentyp

boolean

Alias
UMLS CUI [1]
C0359086
judged by the investigator to be eligible for an insulin analogue plus oral antidiabetic drug treatment regimen
Beschreibung

Indication Insulin regime | Insulin Analogue | Oral hypoglycemic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0557978
UMLS CUI [2]
C2825028
UMLS CUI [3]
C0359086
bmi below 40 kg/m2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
hba1c between 7-12%
Beschreibung

Glycosylated hemoglobin A

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
able and willing to perform self-plasma glucose monitoring
Beschreibung

Plasma Glucose Measurement Self Monitoring Willing

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0202042
UMLS CUI [1,2]
C0588436
UMLS CUI [1,3]
C0600109
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
the receipt of any other investigational drug within 4 weeks before screening
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
a history of drug or alcohol abuse within the last 12 months
Beschreibung

Substance Use Disorders

Datentyp

boolean

Alias
UMLS CUI [1]
C0038586
severe, uncontrolled hypertension
Beschreibung

Uncontrolled hypertension Severe

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C0205082
known or suspected allergy to trial products or related products
Beschreibung

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0439849
UMLS CUI [2,4]
C0013230

Ähnliche Modelle

Eligibility Diabetes NCT00619697

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00619697
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetes for at least 6 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Insulin Therapy naive | Insulin, Short-Acting
Item
insulin naive. short term insulin treatment (7 days or less within the last 6 months) is allowed
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0356365 (UMLS CUI [2])
Oral hypoglycemic
Item
previous treatment with oral antidiabetic drugs for at least 4 months
boolean
C0359086 (UMLS CUI [1])
Indication Insulin regime | Insulin Analogue | Oral hypoglycemic
Item
judged by the investigator to be eligible for an insulin analogue plus oral antidiabetic drug treatment regimen
boolean
C3146298 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
C2825028 (UMLS CUI [2])
C0359086 (UMLS CUI [3])
Body mass index
Item
bmi below 40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c between 7-12%
boolean
C0019018 (UMLS CUI [1])
Plasma Glucose Measurement Self Monitoring Willing
Item
able and willing to perform self-plasma glucose monitoring
boolean
C0202042 (UMLS CUI [1,1])
C0588436 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Investigational New Drugs
Item
the receipt of any other investigational drug within 4 weeks before screening
boolean
C0013230 (UMLS CUI [1])
Substance Use Disorders
Item
a history of drug or alcohol abuse within the last 12 months
boolean
C0038586 (UMLS CUI [1])
Uncontrolled hypertension Severe
Item
severe, uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related Investigational New Drugs
Item
known or suspected allergy to trial products or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0013230 (UMLS CUI [2,4])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video